查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1976690

助行器市场：依产品类型、技术、最终用户和通路划分－2026-2032年全球预测

Walking Assist Devices Market by Product Type, Technology, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，助行器市值将达到 39.1 亿美元，到 2026 年将成长至 41.9 亿美元，到 2032 年将达到 64.6 亿美元，复合年增长率为 7.42%。

主要市场统计数据
基准年 2025 39.1亿美元
预计年份：2026年 41.9亿美元
预测年份 2032 64.6亿美元
复合年增长率 (%) 7.42%

助行器市场正处于人口结构变化、技术整合和医疗服务模式演变的交汇点。人口老化加剧和行动障碍疾病的增加正在推动对助行器的需求。同时，机器人技术、材料科学和感测器技术的进步正在拓展产品的功能，使其超越基本的机械支撑。因此，从临床医生到支付方等相关人员都在重新评估助行器的有效性、安全性和价值。

临床研究和真实世界数据表明，辅助设备不仅能帮助患者行走，还能促进復原效果，​​并提高患者的独立生活能力。这促使製造商加大对人体工学设计、自适应控制系统以及与数位健康平台整合的投入。同时，供应链趋势和监管力道也在影响产品设计、测试要求和上市时间。这些因素共同推动行动辅助设备市场从同质化产品转变为整合硬体、软体和服务交付的差异化解决方案。

本文强调了产业相关人员亟需调整其创新路线，以适应不断变化的临床需求和报销框架。策略性地优先考虑互通性、临床医生培训和以使用者为中心的设计，将决定哪些产品能够在临床实践中广泛应用和长期永续性。

机器人技术、感测器智慧、分散式医疗服务以及以结果为导向的商业模式正在改变产品和服务策略。

在技​​术创新、医疗服务模式转变以及人们对治疗效果日益增长的期望的推动下，步行辅助设备领域正经历着一场变革。机器人和外骨骼技术正从研究机构走向临床应用和社区，提供主动辅助，与传统的被动式设备互补。同时，感测器和机器学习技术的进步正在改善自适应控制、跌倒侦测和个人化辅助功能，从而提升安全性和治疗价值。

分析 2025 年美国关税调整对整个助行设备生态系统的采购、成本结构和供应链策略的影响。

关税等政策工具会对助行器製造商、供应商和经销商的全球供应链和商业经济产生重大影响。在美国，2025 年的关税政策变化迫使製造商重新评估筹资策略、投入成本管理和跨境物流。特定零件和成品进口关税的提高推高了到岸成本，促使企业探索替代供应链和本地生产方案。

将产品差异、护理环境、分销网络以及主动技术和被动技术之间的差异联繫起来的详细細項分析，将有助于制定有针对性的商业化策略。

细緻的市场区隔分析揭示了产品、终端用户、分销和技术等方面的显着差异，指南策略重点和资源分配。从产品类型来看，市场可分为手杖、拐杖、外骨骼、矫正器具和助行器等类别，并可进一步细分。具体而言，手杖类别包括四点式和单点式手杖的各种变体；拐杖类别包括腋拐和前臂拐；外骨骼类别细分为全身系统和下肢系统；矫正器具类别包括踝矫正器具、髋矫正器具和膝关节矫正器具；助行器类别则区分为可助行器和标准助行滚动器。每种产品类别都面临不同的临床预期、监管要求和使用者接受障碍，因此不可能将单一的产品策略普遍应用于所有类型。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势决定了行动辅助解决方案的监管方法、扩散驱动因素和商业化路径。

地理特征影响行动辅助设备的临床应用模式、报销模式、製造地和监管路径。在美洲，医疗保健系统结合了私人和公共报销方式，除了传统的行动辅助设备外，对先进的復健技术也有显着的需求。该地区的市场参与企业优先考虑的是产生临床证据、与康復机构合作以及与保险公司合作，以支持保险覆盖决策和临床医生主导的推广应用。

深入了解影响行动技术领域企业级竞争力的竞争定位、策略伙伴关係关係、智慧财产权的重要性以及服务生态系统。

步行辅助设备领域的竞争格局由差异化的技术平台、临床检验能力和服务生态系统决定。主要企业和新参与企业采取互补的策略：成熟的医疗设备製造商利用分销网络和临床关係来推进渐进式创新，而专业的机器人公司和Start-Ups则致力于开发主动式辅助技术和新型控制系统，以拓展治疗可能性。这些企业之间的合作十分普遍，策略联盟、授权协议和共同开发契约等合作方式加速了复杂系统的临床应用。

为了在行动解决方案领域建立强大的竞争优势，我们采取了切实可行的策略重点，强调模组化设计、临床证据、服务扩展和地理多元化。

产业领导者应优先考虑切实可行的策略，以平衡短期韧性和长期差异化。首先，应优先发展模组化产品架构和灵活的零件采购，以降低贸易政策波动带来的风险，并加速产品线的迭代更新。透过设计支援被动和主动技术的共用平台，企业既能满足多样化的临床需求，又能实现规模经济。

调查方法结合了专家访谈、二手技术和政策分析以及资料三角验证，以得出检验的见解和可操作的建议。

本调查方法结合了专家定性研究和同行评审文献、监管文件和公共资料，以确保证据基础的全面性。主要研究包括对临床医生、復健专家、采购经理和医疗设备开发人员进行结构化访谈，以检验应用场景、推广障碍和技术要求。此外，还对产品规格、安全标准和近期临床试验进行了技术审查，以评估性能特征和监管影响。

总之，我们将整合技术、监管和商业性要求，以确定哪些因素将决定哪些行动辅助解决方案能够实现临床部署和永续的市场相关性。

行动辅助设备产业正从通用型行动装置向更复杂的生态系统转型，该生态系统融合了机械设计、主动辅助技术、数位化服务和以结果为导向的商业模式。这项转变的驱动力来自人口结构变化、机器人和感测器技术的创新，以及强调分散式居家復健路径的医疗服务模式的变革。因此，能够整合临床证据、适应性产品设计和可扩展服务模式，从而为患者和支付方带来实际利益的企业，将成为成功的组织。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 助行器市场：依产品类型划分

  • 拐杖
    • 四脚拐杖
    • 单点拐杖
  • 拐杖
    • 腋下拐杖
    • 前臂拐杖
  • 外骨骼
    • 全身
    • 下肢
  • 矫正器具
    • 踝矫正器具
    • 髋关节矫正器具
    • 矫正器具
  • 沃克
    • 滚轴步行者
    • 标准助行器

第九章：助行器市场：依技术划分

  • 积极的
    • 电的
    • 气动型
  • 被动的
    • 油压
    • 弹簧型

第十章 助行器市场：依最终用户划分

  • 居家照护
  • 医院
  • 復健中心

第十一章 助行器市场：依通路划分

  • 医院和诊所
  • 网路药房
  • 零售药房

第十二章 助行器市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：助行器市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 助行器市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国助行器市场

第十六章：中国助行器市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Bionik Labs Corp.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • Hocoma AG
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • Parker-Hannifin Corporation
  • Permobil Inc
  • Pride Mobility Products Corporation
  • ReWalk Robotics Ltd.
  • RxFunction, Inc.
  • Shenzhen Zuowei Technology Co., Ltd.
  • Stryker Corporation
  • Sunrise Medical（US）LLC
  • Synetik ErgoCare
  • Wandercraft SAS
  • Yattil Industry Co., Ltd.
Product Code: MRR-69324464D216

The Walking Assist Devices Market was valued at USD 3.91 billion in 2025 and is projected to grow to USD 4.19 billion in 2026, with a CAGR of 7.42%, reaching USD 6.46 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.91 billion
Estimated Year [2026] USD 4.19 billion
Forecast Year [2032] USD 6.46 billion
CAGR (%) 7.42%

The walking assist devices landscape is at the intersection of demographic shifts, technological convergence, and evolving care delivery models. Aging populations and rising prevalence of mobility-impairing conditions are increasing demand for mobility aids, while simultaneous advances in robotics, materials science, and sensor technology are expanding product capabilities beyond basic mechanical support. As a result, stakeholders from clinicians to payers are recalibrating evaluations of efficacy, safety, and value.

Clinical research and real-world evidence are reinforcing the role of devices that not only enable ambulation but also contribute to rehabilitation outcomes and independence. This has prompted manufacturers to invest in ergonomic design, adaptive control systems, and integration with digital health platforms. Meanwhile, supply chain dynamics and regulatory scrutiny are shaping product design, testing requirements, and commercialization timelines. Taken together, these forces are driving a transition from commoditized mobility aids to differentiated solutions that blend hardware, software, and service delivery.

This introduction frames the urgency for industry players to align innovation pipelines with evolving clinical needs and reimbursement frameworks. Strategic prioritization of interoperability, clinician training, and user-centered design will determine which offerings achieve meaningful clinical adoption and long-term viability.

Transformative changes driven by robotics, sensor intelligence, decentralized care delivery, and outcome-oriented commercial models reshaping product and service strategies

The landscape for walking assist devices is undergoing transformative shifts driven by technological innovation, changing care delivery paradigms, and heightened expectations for outcomes. Robotics and exoskeleton technologies are moving from research labs into clinical and community settings, enabling active assistance that complements traditional passive devices. At the same time, advances in sensors and machine learning are improving adaptive control, fall detection, and personalized assistance, thereby enhancing safety and therapeutic value.

Concurrently, healthcare delivery models are decentralizing: rehabilitation is increasingly delivered in outpatient clinics, home-based programs, and hybrid care pathways that combine in-person therapy with remote monitoring. This decentralization raises demand for devices that are portable, easy to use, and supported by remote clinician interfaces. Regulatory pathways are also evolving to accommodate software-driven features and connected medical devices, which requires developers to prioritize cybersecurity, data privacy, and post-market surveillance.

Moreover, business models are shifting toward bundled services, outcome-based contracting, and device-as-a-service offerings that align vendor incentives with patient outcomes. These transformative shifts require manufacturers and providers to collaborate on clinical validation, training, and reimbursement strategies to ensure sustained adoption and meaningful clinical impact.

Analysis of how 2025 tariff adjustments in the United States are reshaping sourcing, cost structures, and supply chain strategies across the walking assist devices ecosystem

Policy instruments such as tariffs can materially affect the global supply chains and commercial economics of walking assist device manufacturers, suppliers, and distributors. In the United States, tariff policy changes in 2025 have amplified the need for manufacturers to reassess sourcing strategies, input cost management, and cross-border logistics. Increased import duties on certain components and finished goods raise landed costs and incentivize firms to evaluate alternative supply networks or localized production options.

As a consequence, companies are responding with a mix of tactical and strategic measures. Some are diversifying supplier bases across producing regions to mitigate single-source dependency, while others are accelerating nearshoring or onshoring initiatives to reduce exposure to trade policy volatility. Procurement teams are renegotiating contracts to include tariff pass-through clauses or to lock in pricing, while product teams are exploring design adjustments that reduce reliance on tariff-affected components.

These tariff-driven adjustments also influence distribution and channel strategies. Distributors and clinic networks may shift inventory strategies to buffer against cost fluctuations, and manufacturers may revisit margin structures or service bundles to preserve market access. Importantly, regulatory compliance and customs documentation requirements have become more prominent considerations in commercial planning, underscoring the need for integrated cross-functional responses to trade policy shifts.

Deep segmentation analysis linking product variants, care settings, distribution networks, and active versus passive technology distinctions to guide focused commercialization strategies

A nuanced segmentation view reveals distinct product, end-user, distribution, and technology dynamics that inform strategic priorities and resource allocation. When examining product type, the market spans Cane, Crutch, Exoskeleton, Orthosis, and Walker categories, with further differentiation such that the Cane category includes Quad Cane and Single-Point Cane variants, the Crutch category encompasses Axillary Crutch and Forearm Crutch, the Exoskeleton category subdivides into Full Body and Lower Limb systems, the Orthosis category contains Ankle Brace, Hip Brace, and Knee Brace devices, and the Walker category distinguishes Rollator Walker and Standard Walker configurations. Each product family faces different clinical expectations, regulatory considerations, and user adoption barriers, meaning that a single product strategy cannot be universally applied across types.

Across end users, care settings such as Home Care, Hospital, and Rehabilitation Center impose divergent requirements for device durability, training, maintenance, and reimbursement. Home care environments prioritize ease of use, portability, and remote support, whereas hospitals demand robustness, infection control compatibility, and integration with clinical workflows; rehabilitation centers emphasize therapeutic efficacy and device adjustability for progressive regimens. Distribution channel dynamics further shape access and commercialization, with Hospital Clinics, Online Pharmacy, and Retail Pharmacy channels each presenting distinct inventories, fulfillment models, and point-of-sale interactions that influence how devices are presented to clinicians and consumers.

From a technology standpoint, the active versus passive distinction drives performance and regulatory profiles. Active technologies include Motorized and Pneumatic actuation systems that offer powered assistance and require advanced control architectures and safety interlocks, while passive technologies comprising Hydraulic and Spring Based mechanisms offer lower-cost, maintenance-light solutions with simpler regulatory pathways. Strategic positioning should therefore align product development, clinical validation, and go-to-market plans with the specific segmentation attributes that define end-user expectations and reimbursement pathways.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine regulatory approaches, adoption drivers, and commercialization pathways for mobility solutions

Geographic dynamics shape clinical adoption patterns, reimbursement models, manufacturing footprints, and regulatory pathways for walking assist devices. In the Americas, healthcare systems exhibit a mix of private and public reimbursement approaches and demonstrate significant demand for advanced rehabilitation technologies alongside traditional mobility aids. Market participants in this region are prioritizing clinical evidence generation, partnerships with rehabilitation providers, and payer engagement to support coverage decisions and clinician-led adoption.

In Europe, Middle East & Africa, regulatory heterogeneity and varied healthcare infrastructure create both challenges and opportunities. Advanced markets within this region emphasize conformity with rigorous safety and performance standards and favor integrated care models, while emerging markets present opportunities for lower-cost, scalable solutions and distribution partnerships that extend reach into under-resourced settings. Strategic entrants must navigate diverse regulatory regimes, local reimbursement frameworks, and varying clinician training capacities.

Asia-Pacific encompasses a wide spectrum from highly advanced healthcare systems investing in robotics and digital health solutions to rapidly growing markets where demographic trends drive rising demand for accessible mobility aids. Manufacturers and distributors operating in this region are balancing investments in localized manufacturing and regulatory approvals with digital channels and service models that address urban and rural care delivery differentials. Across all regions, cross-border collaborations, technology transfer agreements, and adaptive commercialization models are becoming essential to capture regional opportunities effectively.

Insights into competitive positioning, strategic partnerships, intellectual property importance, and service ecosystems shaping company-level advantages in mobility technology

Competitive dynamics in the walking assist devices sector are defined by differentiated technology platforms, clinical validation capabilities, and service ecosystems. Leading players and new entrants are pursuing complementary strategies: established medical device companies are leveraging distribution networks and clinical relationships to scale incremental innovations, while specialized robotics firms and startups are advancing active-assist technologies and novel control systems that expand therapeutic possibilities. Collaboration between these groups is common, with strategic partnerships, licensing agreements, and co-development arrangements accelerating time-to-clinic for complex systems.

Intellectual property portfolios around actuator design, control algorithms, and sensor fusion are increasingly valuable, and firms investing in meaningful clinical evidence and real-world data collection strengthen their regulatory positioning and payer negotiations. Manufacturing scalability, quality systems, and global regulatory expertise differentiate firms that can supply hospitals and rehabilitation centers at scale from those focused on niche home-care segments. Additionally, after-sales service capabilities, training programs for clinicians, and digital platforms for remote monitoring are emerging as important competitive levers that sustain device utilization and customer satisfaction.

Investors and corporate development teams are watching consolidation and alliance activity closely. Mergers and acquisitions, strategic minority investments, and targeted collaborations are shaping the competitive map, as organizations seek to combine clinical credibility, distribution reach, and cutting-edge technology to deliver comprehensive mobility solutions.

Actionable strategic priorities emphasizing modular design, clinical evidence, service expansion, and geographic diversification to build resilient competitive advantage in mobility solutions

Industry leaders should pursue a set of actionable priorities that balance near-term resilience with long-term differentiation. First, prioritize modular product architectures and adaptable component sourcing to reduce exposure to trade policy disruptions and to accelerate iteration across product lines. By designing shared platforms that accommodate both passive and active technologies, organizations can realize economies of scale while addressing diverse clinical needs.

Second, invest in robust clinical evidence programs and post-market data collection to demonstrate therapeutic value and to support payer discussions. Collaborative studies with rehabilitation centers and hospitals can generate the outcomes data required to underpin reimbursement conversations and clinician adoption. Third, expand service capabilities around training, remote monitoring, and maintenance to increase device utilization and customer retention; integrating digital care pathways will improve patient adherence and clinical oversight.

Fourth, pursue strategic geographic diversification of manufacturing and distribution to mitigate tariff-related risks while preserving market access. Fifth, cultivate partnerships with robotics specialists, materials innovators, and software developers to accelerate the development of next-generation active-assist systems. Finally, align commercial models with stakeholder incentives by experimenting with device-as-a-service offerings and outcome-based agreements that can lower adoption barriers for high-cost technologies.

Methodological approach combining expert interviews, secondary technical and policy analysis, and data triangulation to produce validated insights and actionable recommendations

The research methodology combined primary qualitative engagement with subject-matter experts and secondary synthesis of peer-reviewed literature, regulatory documentation, and public policy materials to ensure a comprehensive evidence base. Primary research included structured interviews with clinicians, rehabilitation specialists, procurement leaders, and device developers to validate use-case scenarios, adoption barriers, and technology requirements. These interviews were complemented by technical reviews of product specifications, safety standards, and recent clinical trials to assess performance characteristics and regulatory implications.

Secondary research encompassed academic journals, standards bodies, device registries, and government policy announcements to construct a contextual framework around demographics, care delivery trends, and trade policy impacts. Data triangulation was applied across sources to corroborate qualitative insights and to identify convergent themes. Analytical approaches included comparative technology assessments, channel mapping, and scenario analysis to evaluate strategic implications of tariffs, supply chain shifts, and regional regulatory variance.

Throughout the process, findings were validated through iterative expert reviews and cross-functional stakeholder consultations to ensure practical relevance and methodological rigor. This approach ensures that recommendations are grounded in clinical realities, regulatory constraints, and operational considerations relevant to manufacturers, providers, and payers.

Conclusion synthesizing technological, regulatory, and commercial imperatives that will determine which mobility solutions achieve clinical adoption and sustained market relevance

The walking assist devices sector is transitioning from commodity-oriented mobility aids to a more sophisticated ecosystem that blends mechanical design, active-assist technologies, digital services, and outcome-focused commercial models. This evolution is driven by demographic demand, innovations in robotics and sensors, and shifts in care delivery that favor decentralized, home-centric rehabilitation pathways. As a result, successful organizations will be those that integrate clinical evidence, adaptive product design, and scalable service models that demonstrate tangible benefits to patients and payers.

Trade policy shifts and supply chain reconfiguration have elevated the importance of sourcing flexibility and regional manufacturing strategies, while distribution channels are evolving to include a stronger role for online and retail pharmacy channels alongside traditional hospital clinic procurement. Competitive advantage will accrue to companies that align technology investments with clinician workflows, invest in training and post-market support, and pursue partnerships that complement in-house capabilities. Ultimately, the most resilient strategies will marry technical innovation with pragmatic commercialization plans that address regulatory compliance, reimbursement dynamics, and end-user usability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Walking Assist Devices Market, by Product Type

  • 8.1. Cane
    • 8.1.1. Quad Cane
    • 8.1.2. Single-Point Cane
  • 8.2. Crutch
    • 8.2.1. Axillary Crutch
    • 8.2.2. Forearm Crutch
  • 8.3. Exoskeleton
    • 8.3.1. Full Body
    • 8.3.2. Lower Limb
  • 8.4. Orthosis
    • 8.4.1. Ankle Brace
    • 8.4.2. Hip Brace
    • 8.4.3. Knee Brace
  • 8.5. Walker
    • 8.5.1. Rollator Walker
    • 8.5.2. Standard Walker

9. Walking Assist Devices Market, by Technology

  • 9.1. Active
    • 9.1.1. Motorized
    • 9.1.2. Pneumatic
  • 9.2. Passive
    • 9.2.1. Hydraulic
    • 9.2.2. Spring Based

10. Walking Assist Devices Market, by End User

  • 10.1. Home Care
  • 10.2. Hospital
  • 10.3. Rehabilitation Center

11. Walking Assist Devices Market, by Distribution Channel

  • 11.1. Hospital Clinics
  • 11.2. Online Pharmacy
  • 11.3. Retail Pharmacy

12. Walking Assist Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Walking Assist Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Walking Assist Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Walking Assist Devices Market

16. China Walking Assist Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Bionik Labs Corp.
  • 17.6. Cyberdyne Inc.
  • 17.7. Ekso Bionics Holdings, Inc.
  • 17.8. Hocoma AG
  • 17.9. Myomo, Inc.
  • 17.10. Ottobock SE & Co. KGaA
  • 17.11. Parker-Hannifin Corporation
  • 17.12. Permobil Inc
  • 17.13. Pride Mobility Products Corporation
  • 17.14. ReWalk Robotics Ltd.
  • 17.15. RxFunction, Inc.
  • 17.16. Shenzhen Zuowei Technology Co., Ltd.
  • 17.17. Stryker Corporation
  • 17.18. Sunrise Medical (US) LLC
  • 17.19. Synetik ErgoCare
  • 17.20. Wandercraft SAS
  • 17.21. Yattil Industry Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WALKING ASSIST DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL WALKING ASSIST DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY QUAD CANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY QUAD CANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY QUAD CANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SINGLE-POINT CANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SINGLE-POINT CANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SINGLE-POINT CANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY AXILLARY CRUTCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY AXILLARY CRUTCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY AXILLARY CRUTCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FOREARM CRUTCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FOREARM CRUTCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FOREARM CRUTCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FULL BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FULL BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FULL BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ANKLE BRACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ANKLE BRACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ANKLE BRACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HIP BRACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HIP BRACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HIP BRACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY KNEE BRACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY KNEE BRACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY KNEE BRACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ROLLATOR WALKER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ROLLATOR WALKER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ROLLATOR WALKER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY STANDARD WALKER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY STANDARD WALKER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY STANDARD WALKER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY MOTORIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY MOTORIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY MOTORIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HYDRAULIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HYDRAULIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HYDRAULIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SPRING BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SPRING BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SPRING BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY REHABILITATION CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY REHABILITATION CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY REHABILITATION CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. GCC WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 211. GCC WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 212. GCC WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 213. GCC WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 214. GCC WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 217. GCC WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GCC WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. G7 WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 247. G7 WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 248. G7 WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. G7 WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 253. G7 WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. G7 WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. NATO WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 259. NATO WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 260. NATO WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 262. NATO WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. NATO WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 264. NATO WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 265. NATO WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. NATO WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)